Events 11/05/24 “The 2nd KHIDI-AMED Joint Symposium”－Advancing Neuroscience: New Frontiers in Overcoming Dementia－
Event Information
We are pleased to present the latest research and development trends and achievements in the field of dementia from both Japan and South Korea. This symposium will provide an opportunity for experts to exchange views on the early diagnosis and treatment of dementia.
For more information, please visit the website below.
The 2nd KHIDI-AMED Joint Symposium
This symposium will be a hybrid event where you can participate either on site or online.
Name
“The 2nd KHIDI-AMED Joint Symposium”－Advancing Neuroscience: New Frontiers in Overcoming Dementia－
Date & Time
Venue
The Westin Josun Seoul
106 Sogong-ro, Jung-gu, Seoul, 100-070, Korea
Online participation will be on a Zoom webinar. The URL will be provided to those who have registered to participate.
Capacity
Onsite Participation: 100 people（Advance registration required: Registration will close once the capacity has been reached.）
Online Participation: 500 people（Advance registration required: Registration will close once the capacity has been reached. ）
Fee
Free (*Transportation and communication expenses to be borne by the applicant.)
How to Apply
Please apply from the links below and choose to participate at the venue or online.
(Registration deadline: Wednesday, October 30th, 17:00）
Please note that registration will end as soon as the capacity has been reached.
Organizer
Japan Agency for Medical Research and Development (AMED)
The Korean Health Industry Development Institute (KHIDI)
Program
| Program | |
|---|---|
| Opening Remarks | President, Dr. Soondo Cha The Korean Health Industry Development Institute (KHIDI) |
| Opening Remarks | President, Dr. MISHIMA Yoshinao The Japan Agency for Medical Research and Development (AMED) |
| Vascular permeability: New MR imaging marker for AD | Prof. Won-Jin Moon, MD, PhD Department of Radiology, Konkuk University Medical Center, Konkuk University School of Medicine |
| Neuroimaging-based diagnosis of dementing disorders targeting cerebral proteinopathies | Dr. HIGUCHI Makoto, MD, PhD Director, Advanced Neuroimaging Center, National Institutes for Quantum Science and Technology |
| Hemodiagnosis of Alzheimer’s disease via nanoplasmonic biosensor for precision medicine | Prof. Sang Jun Sim, PhD Professor, Department of Chemical and Biological Engineering Director, BK21 Program of Chemical and Biological Engineering, Korea University Director, Institute of Chemical Engineering Convergence Systems, Korea University |
| Classification of neurodegenerative diseases based on conformation of pathogenic proteins | Dr. TARUTANI Airi, PhD Researcher, Department of Brain and Neurosciences, Tokyo Metropolitan Institute of Medical Science |
| Toward inflammation free therapeutics for Alzheimer's disease | Prof. Won-Suk Chung Associate Director, Center for Vascular Research, Institute for Basic Science (IBS) Associate Professor, Department of Biological Sciences, Korea Advanced Institute for Science and Technology (KAIST) |
| Novel Strategies for Enhanced Amyloid Clearance for Alzheimer Disease | Prof. TOMITA Taisuke, PhD Professor, Graduate School of Pharmaceutical Sciences, The University of Tokyo |
| The AUTOTAC chemical platform for targeted protein degradation in drug development: IND-enabling preclinical studies in neurodegeneration | Prof. Yongtae Kwon, PhD Professor, Department of Biomedical Sciences, Seoul National University School of Medicine CEO, AUTOTAC Bio Inc. |
| Implementing anti-Aβ therapy in the real-world. Challenges and lessons learned | Dr. IWATA Atsushi, MD, PhD Vice President, Tokyo Metropolitan Institute for Geriatrics and Gerontology |
| Panel discussion | |
Contact
| Division Name |
Japan-Korea Symposium Secretariat Department of International Strategy, Japan Agency for Medical Research and Development (AMED) |
|---|---|
| amed-khidi ”AT”amed.go.jp | |
| Remarks |
Replace "AT" with “@"
|
Last updated 10/23/24